CAR-DC Vaccine and ICIs in Local Advanced/Metastatic Solid Tumors

Clinical trial NCT05631899 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05631899
Sponsor: Chinese PLA General Hospital
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumor, Adult EphA2 Overexpression KRAS G12V KRAS G12C KRAS G12D

Start date: 2023-04-03
Primary completion: 2026-06-30
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.